Back to HRTX
MARSHALL WACE, LLP HRTX Position History
Heron Therapeutics, Inc. • Healthcare
Quarters held
15
Latest value
$109K
Q3 2026
Peak value
$6M
First seen
Q1 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2024 | $1.4M |
| Q2 2024 | $164K |
| Q2 2024 | $6M |
| Q3 2024 | $3.4M |
| Q4 2024 | $1.6M |
| Q1 2025 | $276K |
| Q1 2025 | $2.5M |
| Q2 2025 | $1M |
| Q2 2025 | $4.9M |
| Q3 2025 | $72K |
| Q3 2025 | $1.6M |
| Q2 2026 | $105K |
| Q2 2026 | $907K |
| Q3 2026 | $1K |
| Q3 2026 | $109K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $109K | 352.7K | — | — |
| Q3 2026 | $1K | 4.8K | — | — |
| Q2 2026 | $907K | 2.11M | — | — |
| Q2 2026 | $105K | 244.6K | — | — |
| Q3 2025 | $1.6M | 1.25M | — | — |
| Q3 2025 | $72K | 57.5K | — | — |
| Q2 2025 | $4.9M | 2.39M | — | — |
| Q2 2025 | $1M | 506.4K | — | — |
| Q1 2025 | $2.5M | 1.13M | — | — |
| Q1 2025 | $276K | 125.3K | — | — |
| Q4 2024 | $1.6M | 1.02M | — | — |
| Q3 2024 | $3.4M | 1.72M | — | — |
| Q2 2024 | $6M | 1.71M | — | — |
| Q2 2024 | $164K | 46.7K | — | — |
| Q1 2024 | $1.4M | 494.4K | — | — |